DCF — NORTHEAST GEORGIA MEDICAL CENTER
Enterprise Value: $404.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$404.9M
Enterprise Value
$79.3M
PV of Cash Flows
$325.6M
PV of Terminal Value
$524.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.6B | $78.3M | 5.0% | $1.2M | $1.1M |
| Year 2 | $1.6B | $97.1M | 6.0% | $13.5M | $11.2M |
| Year 3 | $1.7B | $117.0M | 7.0% | $26.6M | $20.0M |
| Year 4 | $1.7B | $129.2M | 7.0% | $34.0M | $23.2M |
| Year 5 | $1.8B | $137.6M | 8.0% | $38.4M | $23.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $404.9M. Terminal value accounts for 80% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.5B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.044097385988112206
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5